Mirakhur B - Search Results

1

Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Saif MW, et al. Among authors: mirakhur b. J Gastrointest Oncol. 2019 Aug;10(4):674-687. doi: 10.21037/jgo.2019.03.11. J Gastrointest Oncol. 2019. PMID: 31392048 Free PMC article.

2

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.

Dromain C, Loaiza-Bonilla A, Mirakhur B, Beveridge TJR, Fojo AT. Dromain C, et al. Among authors: mirakhur b. Oncologist. 2021 Apr;26(4):e632-e638. doi: 10.1002/onco.13669. Epub 2021 Feb 1. Oncologist. 2021. PMID: 33393112 Free PMC article.

3

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial.

Blot K, Duchateau L, Lescrauwaet B, Liyanage N, Ray D, Mirakhur B, Vinik AI. Blot K, et al. Among authors: mirakhur b. Patient Relat Outcome Meas. 2019 Oct 29;10:335-343. doi: 10.2147/PROM.S219982. eCollection 2019. Patient Relat Outcome Meas. 2019. PMID: 31754316 Free PMC article.

4

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.

Fisher MD, Pulgar S, Kulke MH, Mirakhur B, Miller PJ, Walker MS, Schwartzberg LS. Fisher MD, et al. Among authors: mirakhur b. J Gastrointest Cancer. 2019 Dec;50(4):816-823. doi: 10.1007/s12029-018-0160-x. J Gastrointest Cancer. 2019. PMID: 30121904 Free PMC article.

5

Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.

Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA Jr, Vinik AI; CLARINET Study Investigators. Pavel ME, et al. Among authors: mirakhur b. Oncologist. 2019 Apr;24(4):463-474. doi: 10.1634/theoncologist.2018-0217. Epub 2018 Oct 24. Oncologist. 2019. PMID: 30355775 Free PMC article. Clinical Trial.

6

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals.

Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TG, Phan AT. Ortendahl JD, et al. Among authors: mirakhur b. Clinicoecon Outcomes Res. 2017 Aug 16;9:495-503. doi: 10.2147/CEOR.S140866. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 28860831 Free PMC article.

7

Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.

Fisher GA Jr, Wolin EM, Liyanage N, Pitman Lowenthal S, Mirakhur B, Pommier RF, Shaheen M, Vinik A; ELECT Study Group. Fisher GA Jr, et al. Among authors: mirakhur b. Oncologist. 2018 Jan;23(1):16-24. doi: 10.1634/theoncologist.2017-0284. Epub 2017 Oct 16. Oncologist. 2018. PMID: 29038234 Free PMC article. Clinical Trial.

8

Biochemical efficacy of long-acting lanreotide depot/Autogel in patients with acromegaly naïve to somatostatin-receptor ligands: analysis of three multicenter clinical trials.

Alquraini H, Del Pilar Schneider M, Mirakhur B, Barkan A. Alquraini H, et al. Among authors: mirakhur b. Pituitary. 2018 Jun;21(3):283-289. doi: 10.1007/s11102-018-0867-5. Pituitary. 2018. PMID: 29357081 Clinical Trial.

9

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial.

Macarulla T, Blanc JF, Wang-Gillam A, Chen LT, Siveke JT, Mirakhur B, Chen J, de Jong FA. Macarulla T, et al. Among authors: mirakhur b. J Geriatr Oncol. 2019 May;10(3):427-435. doi: 10.1016/j.jgo.2019.02.011. Epub 2019 Mar 4. J Geriatr Oncol. 2019. PMID: 30842038 Free article. Clinical Trial.

10

A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.

Salvatori R, Gordon MB, Woodmansee WW, Ioachimescu AG, Carver DW, Mirakhur B, Cox D, Molitch ME. Salvatori R, et al. Among authors: mirakhur b. Pituitary. 2017 Dec;20(6):605-618. doi: 10.1007/s11102-017-0821-y. Pituitary. 2017. PMID: 28741071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page